SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report April 2, 2003
(Date of earliest event reported) ----------------------------------
MedicaLogic/Medscape, Inc.
(Exact name of registrant as specified in charter)
Oregon 000-28285 93-0890696
- --------------------------------------------------------------------------------
(State or other (Commission file (IRS employer
jurisdiction number) identification no.)
of incorporation)
20540 NW Evergreen Parkway
Hillsboro, Oregon 97124
- --------------------------------------------------------------------------------
(Address of principal executive offices)
Registrant's telephone number, (503) 531-7000
including area code -----------------------------------
Not applicable
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Item 5. Other Events
On January 24, 2002, MedicaLogic/Medscape, Inc. (the "Company") and its
five United States subsidiaries filed a voluntary petition for bankruptcy
protection (collectively, the "Bankruptcy Cases") under Chapter 11 of the U.S.
Bankruptcy Code (the "Code") in the United States Bankruptcy Court for the
District of Delaware (the "Bankruptcy Court"). The Bankruptcy Cases were
assigned to the Honorable Judge Peter J. Walsh and are jointly administered and
coordinated under Case Numbers 02-10253 (PJW) through 02-10258 (PJW). In
addition to the Company, the filing entities were MSCP Holdings, Inc.,
MedicaLogic Enterprises, Inc., MedicaLogic Pennsylvania, LLC, MedicaLogic of
Texas, Inc. and MedicaLogic Texas, L.P. (collectively, with the Company, the
"Debtors").
On November 22, 2002, the Debtors filed a Joint Plan of Liquidation and
related Disclosure Statement in the Bankruptcy Court pursuant to the Code. On
December 20, 2003, the Debtors filed a First Amended Joint Plan of Liquidation
(the "Plan") and related First Amended Disclosure Statement. The Court confirmed
the Plan on March 3, 2003. On April 3, 2003, the Debtors filed with the
Bankruptcy Court a Notice of (1) Entry of Confirmation Order, (2) Occurrence of
Effective Date, and (3) Important Bar Dates announcing, among other things, that
the effective date of the Plan occurred on April 2, 2003 (the "Notice"). The
Notice is attached hereto as Exhibit 99.1
Item 7. Financial Statements and Exhibits.
(c) Exhibits
================================================================================
Exhibit No. Description
99.1 Notice of (1) Entry of Confirmation Order,
(2) Occurrence of Effective Date, and (3) Important
Bar Dates
================================================================================
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: April 8, 2003
MEDICALOGIC/MEDSCAPE, INC.
By: /s/ Hobart T. Truesdall
-----------------------------------
Name: Hobart T. Truesdall
Title: Trustee
EXHIBIT INDEX
================================================================================
99.1 Notice of (1) Entry of Confirmation Order, (2) Occurrence
of Effective Date, and (3) Important Bar Dates
================================================================================